F5 is experiencing a robust hardware refresh cycle, driving double-digit product and systems revenue growth. Check out why ...

For the three months ended June 30, 2026, the Victory RS Partners Fund (A shares without sales charge) underperformed its ...

Wally Weitz discusses AI-driven market concentration and the outlook for diversified portfolios. Read the full commentary for ...

Allspring Common Stock Fund outperformed the Russell 2500 Index in Q2 2026, led by Health care and IT sectors. Read the full ...

Authorized participants do not create or redeem ETF shares for philosophical reasons. They do it to make money, primarily ...

The Allspring Common Stock Fund outperformed its benchmark in Q2 2026, led by strong selection in IT. Read the full analysis ...

During the second quarter of 2026, the largest portfolio sector weightings were Information Technology and Consumer ...

When we published our last detailed outlook on corporate hybrids, we argued that the U.S. market had arrived and that the ...

CRISPR Therapeutics offers a diversified gene-editing pipeline, with CASGEVY as its lead asset and multiple upcoming ...

Harding Loevner reports on the impact of AI supply constraints and evaluates the record-breaking SpaceX IPO. Read the full ...

Saudi Arabia's Public Investment Fund 13F US portfolio decreased from $12.95B to $12B in Q1 2026. Learn more about the ...

AST SpaceMobile delayed its 45-satellite target to early 2027 due to launch constraints. Find out why ASTS stock is upgraded ...